Home Cart 0 Sign in  
X

[ CAS No. 491-37-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 491-37-2
Chemical Structure| 491-37-2
Chemical Structure| 491-37-2
Structure of 491-37-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 491-37-2 ]

Related Doc. of [ 491-37-2 ]

Alternatived Products of [ 491-37-2 ]

Product Details of [ 491-37-2 ]

CAS No. :491-37-2 MDL No. :MFCD00006840
Formula : C9H8O2 Boiling Point : -
Linear Structure Formula :- InChI Key :MSTDXOZUKAQDRL-UHFFFAOYSA-N
M.W : 148.16 Pubchem ID :68110
Synonyms :

Calculated chemistry of [ 491-37-2 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.01
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.76
Log Po/w (XLOGP3) : 1.38
Log Po/w (WLOGP) : 1.65
Log Po/w (MLOGP) : 1.05
Log Po/w (SILICOS-IT) : 2.46
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.03
Solubility : 1.38 mg/ml ; 0.0093 mol/l
Class : Soluble
Log S (Ali) : -1.54
Solubility : 4.32 mg/ml ; 0.0291 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.216 mg/ml ; 0.00146 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.81

Safety of [ 491-37-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 491-37-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 491-37-2 ]
  • Downstream synthetic route of [ 491-37-2 ]

[ 491-37-2 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 491-37-2 ]
  • [ 80096-64-6 ]
Reference: [1] Chemical Communications, 2018, vol. 54, # 18, p. 2252 - 2255
  • 2
  • [ 491-37-2 ]
  • [ 49660-57-3 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: at 20℃; for 0.166667 h;
Stage #2: at 0 - 80℃; for 0.333333 h;
To mechanically stirred neat aluminum trichloride (18.0 g, 135 mmol, 2.50 equiv) was added 4-chromanone (8.00 g, 54.0 mmol) portionwise at room temperature. The resulting brown oil was stirred for 10 minutes and bromine (3.34 mL, 65.8 mmol, 1.20 equiv) was added portionwise. The mixture was stirred for 10 minutes, heated to 80 C for 10 minutes, cooled to 0 C and quenched with careful addition of ice. The mixture was then diluted with ether and water, the organic layer was washed with 1M hydrochloric acid (3x), brine, dried over sodium sulfate, filtered and concentrated. The resulting residue was purified on a 40M Biotage column (0 to 10percent ethyl acetate in hexanes over 30 minutes) to give 7.61 g of 6-BROMO-CHROMAN-4-ONE (Yield: 62percent). The isolated product contains 21percent DIBROMIDE. HL NMR (400 MHz, CDC13) : 8 2.80 (t, 2H), 4.53 (t, 2H), 6.85 (d, 1H), 7.53 (dd, 1H), 7.98 (d, 1H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 16, p. 4405 - 4409
[2] Patent: WO2004/69244, 2004, A1, . Location in patent: Page/Page column 98
  • 3
  • [ 122-97-4 ]
  • [ 254-03-5 ]
  • [ 493-08-3 ]
  • [ 491-37-2 ]
  • [ 19090-04-1 ]
Reference: [1] Journal of Organic Chemistry, 1983, vol. 48, # 25, p. 4914 - 4917
  • 4
  • [ 122-97-4 ]
  • [ 254-04-6 ]
  • [ 254-03-5 ]
  • [ 493-08-3 ]
  • [ 491-37-2 ]
  • [ 19090-04-1 ]
  • [ 100-52-7 ]
Reference: [1] Journal of Organic Chemistry, 1983, vol. 48, # 25, p. 4914 - 4917
  • 5
  • [ 491-37-2 ]
  • [ 55745-97-6 ]
Reference: [1] Patent: WO2013/12649, 2013, A1,
[2] Patent: US2014/243349, 2014, A1,
  • 6
  • [ 491-37-2 ]
  • [ 68043-53-8 ]
Reference: [1] Patent: US2002/25965, 2002, A1,
[2] Patent: US5629321, 1997, A,
[3] Patent: US5719145, 1998, A,
[4] Patent: EP760364, 1997, A2,
[5] Patent: WO2015/38446, 2015, A1, . Location in patent: Page/Page column 48
  • 7
  • [ 491-37-2 ]
  • [ 68043-53-8 ]
  • [ 90322-49-9 ]
YieldReaction ConditionsOperation in experiment
9% at 0℃; for 2 h; /V-(3,4-Dihydro-2W-chromen-6-yl)acetamide (228). A solution of KNO3 (2.25 g, 22.3 mmol) in CH2SO4 (10 mL) was added dropwise to a stirred solution of 4-chromanone (225) (3.0 g, 20.2 mmol) in CH2SO4 (50 mL) at 0 0C and the mixture stirred at 0 0C for 2 h. The mixture was poured into ice/water (500 mL), stirred 30 min and the precipitate filtered. The solid was washed with water (3 x 10 mL) and dried. The solid was purified by chromatography, eluting with 20percent EtOAc/pet. ether, to give (i) 8-nitro-2,3-dihydro-4/-/- chromen-4-one (226) (369 mg, 9percent) as a white solid: mp (EtOAc/pet. ether) 120-121 0C; 1H NMR δ 8.17 (dd, J = 7.8, 1.8 Hz, 1 H, H-7), 8.10 (dd, J = 8.0, 1.8 Hz, 1 H, H-5), 7.12 (dd, J = 8.0, 7.8 Hz, 1 H, H-6), 4.73 (dd, J = 6.5, 6.4 Hz, 2 H, H-2), 2.95 (br t, J = 6.5 Hz, 2 H, H-3). Anal, calcd for C9H7NO4: C, 56.0; H, 3.7; N, 7.3. Found: C, 56.1; H, 3.7; N, 7.3percent; and (ii) 6-nitro-2,3-dihydro-4/-/-chromen-4-one (227) (3.17 g, 81percent) as a white solid: mp (EtOAc/pet. ether) 169-171 0C; 1H NMR δ 8.78 (d, J = 2.8 Hz, 1 H, H-5), 8.32 (dd, J = 9.1, 2.8 Hz, 1 H, H-7), 7.11 (d, J = 9.1 Hz, 1 H, H-8), 4.67 (dd, J = 6.6, 6.4 Hz, 2 H, H-2), 2.91 (dd, J = 6.6, 6.4 Hz, 2 H, H-3); 13C NMR δ 189.4, 165.7, 142.1, 130.3, 123.7, 120.8, 119.3, 67.6, 37.1. Anal, calcd for C9H7NO4: C, 56.0; H, 3.7; N, 7.3. Found: C, 56.1; H, 3.7; N, 7.4percent.A mixture of nitrochromanone 227 (2.0 g, 13.4 mmol) and Pd/C (5percent, 100 mg) in EtOH/EtOAc (4:1, 150 mL), water (10 mL), and cHCI (1 mL) was stirred under H2 (60 psi) for 16 h. The mixture was filtered through celite, washed with EtOH (3 x 25 mL) and the solvent evaporated. The residue was partitioned between dilute aqueous NH3 solution and DCM, the organic fraction dried, and the solvent evaporated. The residue was dissolved in dry dioxane (100 mL) and Ac2O (2.8 mL, 29.4 mmol) added dropwise. The solution was stirred at 20 0C for 16 h, diluted with water and the solvent evaporated. The residue was purified by chromatography, eluting with a gradient (50-100percent) of EtOAc/pet. ether, to give acetamide 228 (2.09 g, 70percent) as a white solid: mp 111-113 0C [lit. (Hach, V. Coll. Czech. Chem. Commun. 1959, 24, 3136-3140) mp (EtOH) 118 0C]; 1H NMR δ 7.28 (d, J = 2.2 Hz, 1 H, H-5), 7.02 (dd, J = 8.6, 2.2 Hz, 1 H, H-7), 6.72 (d, J = 8.6 Hz, 1 H, H-8), 4.15 (br dd, J = 5.2, 5.0 Hz, 2 H, H-2), 2.77 (br t, J = 6.5 Hz, 2 H, H-4), 2.13 (s, 3 H, CH3), 1.95- 2.02 (m, 2 H, H-3).
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 21, p. 6853 - 6865
[2] Patent: WO2006/104406, 2006, A1, . Location in patent: Page/Page column 148
[3] Patent: WO2015/145371, 2015, A1, . Location in patent: Page/Page column 48
  • 8
  • [ 491-37-2 ]
  • [ 68043-53-8 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 21, p. 10568 - 10580
  • 9
  • [ 491-37-2 ]
  • [ 740842-71-1 ]
  • [ 17775-01-8 ]
Reference: [1] Organic Process Research and Development, 2015, vol. 19, # 7, p. 721 - 734
  • 10
  • [ 491-37-2 ]
  • [ 6968-35-0 ]
YieldReaction ConditionsOperation in experiment
75.2%
Stage #1: at 50 - 200℃; for 0.333333 h;
Stage #2: at 0℃; for 0.5 h;
37.0 g (278 mmol) of aluminum chloride was mixed with 3.70 g (61.3 mmol) of sodium chloride, the mixture was dissolved at 150C under heating, 6.40 g (43.2 mmol) of commercially available 2,3-dihydro-4H-chromen-4-one dissolved by heating (50C) was added to the mixture and the resulting mixture was stirred at 200C for 20 minutes. The reaction mixture (gum state) was cooled, and added to ice-cold hydrochloric acid (100 ml of conc. hydrochloric acid and ice were combined to make them 200 ml) little by little and stirred for 30 minutes. Methylene chloride was added to the mixture and the mixture was separated. The aqueous layer was filtered, and the filtrate was extracted with methylene chloride. The organic layers were combined, washed successively with water and brine, and dried over sodium sulfate. The solvent was removed, and the obtained residue was purified by silica gel chromatography (Wakogel C-100, hexane-ethyl acetate, gradient) to obtain 4.82 g (32.6 mmol, Yield: 75.2percent) of 7-hydroxy-1-indanone.
Reference: [1] Patent: EP1426365, 2004, A1, . Location in patent: Page 183
[2] Tetrahedron Letters, 2011, vol. 52, # 9, p. 960 - 963
[3] Organic and Biomolecular Chemistry, 2012, vol. 10, # 3, p. 512 - 515
[4] ChemMedChem, 2018, vol. 13, # 18, p. 1949 - 1956
[5] European Journal of Organic Chemistry, 2016, vol. 2016, # 20, p. 3365 - 3372
[6] Chemistry - A European Journal, 2017, vol. 23, # 56, p. 14080 - 14089
[7] Journal of the Chemical Society, 1954, p. 4299,4301
[8] Scientia Pharmaceutica, 1998, vol. 66, # 3, p. 147 - 158
[9] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 12, p. 2801 - 2809
[10] Patent: WO2015/95261, 2015, A1, . Location in patent: Page/Page column 67
[11] Patent: WO2015/89842, 2015, A1, . Location in patent: Page/Page column 66
  • 11
  • [ 7446-70-0 ]
  • [ 491-37-2 ]
  • [ 6968-35-0 ]
Reference: [1] Journal of the Chemical Society, 1954, p. 4299,4301
  • 12
  • [ 491-37-2 ]
  • [ 40731-98-4 ]
Reference: [1] Patent: US9108916, 2015, B2,
  • 13
  • [ 491-37-2 ]
  • [ 53981-38-7 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With titanium(IV) isopropylate; ammonia In ethanol at 20℃; for 6 h;
Stage #2: With sodium tetrahydroborate In ethanol at 0 - 20℃; for 3.16 h;
Chroman-4-amine :; Chroman-4-one (3 g, 20.1 mmol), titanium(IV) isopropoxide (12.0 niL, 40.2 mmol) and2 M solution of ammonia in ethanol (60.6 mL, 121.2 mmol) were stirred at room temperature for 6 h. The reaction was cooled to 0 °C and sodium borohydride was added portionwise during 10 min. (1.14 g, 30.2 mmol); the resultant mixture was stirred at rt for an additional 3 h. The reaction was quenched by pouring it into ammonium hydroxide (2 M, 60 mL), the precipitate that formed was filtered off and washed with ethyl acetate (15 mL x 3). The organic layer was separated and the remaining aqueous layer was extracted with ethyl acetate (15 mL x 2). The combined organic extracts were washed with 1 M HCl (25 mL). The acidic aqueous extracts were washed with ethyl acetate (50 mL), then treated with aqueous sodium hydroxide (2 M) to pH 10-12, and extracted with ethyl acetate (40 mL x 3). The combined organic extracts were washed with brine, dried (Na2SO4), and concentrated in vacuo to affordChroman-4-amine as an oil (2.61 g, 87 percent yield). 1H NMR (400 MHz, CDCl3) δ 7.31 (d, IH), 7.23 (m, IH), 6.94 (m, IH), 6.82 (d, IH), 4. 38 (m, 2H), 4.12 (m, IH), 2.19 (m, 2H), 1.82 (m, 2H).
Reference: [1] Patent: WO2006/81332, 2006, A1, . Location in patent: Page/Page column 98
[2] Science, 2017, vol. 358, # 6361, p. 326 - 332
[3] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1981, vol. 20, # 12, p. 1063 - 1067
[4] Journal of Organic Chemistry, 2010, vol. 75, # 15, p. 5265 - 5270
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 5, p. 1338 - 1341
[6] Patent: WO2012/62750, 2012, A1,
[7] European Journal of Organic Chemistry, 2014, vol. 2014, # 31, p. 7034 - 7038
[8] Patent: US2003/144297, 2003, A1,
  • 14
  • [ 491-37-2 ]
  • [ 210488-55-4 ]
Reference: [1] Chemistry - A European Journal, 2012, vol. 18, # 7, p. 1969 - 1983
[2] ACS Catalysis, 2013, vol. 3, # 4, p. 555 - 559
[3] Organic Syntheses, 2013, vol. 90, p. 338 - 349
[4] European Journal of Organic Chemistry, 2014, vol. 2014, # 31, p. 7034 - 7038
  • 15
  • [ 491-37-2 ]
  • [ 210488-55-4 ]
  • [ 188198-38-1 ]
Reference: [1] ACS Catalysis, 2013, vol. 3, # 4, p. 555 - 559
  • 16
  • [ 491-37-2 ]
  • [ 188198-38-1 ]
Reference: [1] ACS Catalysis, 2013, vol. 3, # 4, p. 555 - 559
  • 17
  • [ 491-37-2 ]
  • [ 210488-55-4 ]
  • [ 188198-38-1 ]
Reference: [1] ACS Catalysis, 2013, vol. 3, # 4, p. 555 - 559
  • 18
  • [ 491-37-2 ]
  • [ 18442-22-3 ]
YieldReaction ConditionsOperation in experiment
74%
Stage #1: for 0.283333 h;
Stage #2: at 20℃; for 1 h;
7-Bromo-4-chromanone.
Into a round bottom flask kept at 0° C., AlCl3 (0.533 g, 3.99 mmol) and, 5 mL of CH2Cl2 was added.
The reaction system was put under nitrogen and stirred for about 7 minutes before adding 10 mL of a CH2Cl2 solution of 4-chromanone (0.296 g, 1.99 mmol).
After the reaction mixture was stirred for 10 minutes, 10 mL of Br2 (0.352 g, 2.20 mmol) was added and, the reaction mixture was stirred at room temperature for an hour.
At the end of this period of time, the reaction mixture was poured into 30 mL of ice-water and, the product was extracted 3 times from the aqueous phase with EtOAc.
The resultant organic phase was washed once with brine and dried under Na2SO4.
After the solvent was evaporated, the solid formed was filtered and dried to obtain 0.361 g (1.51 mmol) of the product (93percent pure) in a 74percent yield.
1H NMR (300 MHz, CDCl3, δ): 7.90 (dd, J=2.6, 0.3 ArH, 1H,), 7.47 (dd, J=8.8, 2.5, Ar, 1H,), 6.82 (dd, J=8.8, 0.2, Ar, 1H), 4.48 (t, J=6.5, C2, 2H), 2.75 (t, J=6.5, C2, 2H).
Reference: [1] Patent: US2009/76076, 2009, A1, . Location in patent: Page/Page column 24-25
  • 19
  • [ 491-37-2 ]
  • [ 1002727-88-9 ]
Reference: [1] Patent: WO2009/62289, 2009, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 491-37-2 ]

Ketones

Chemical Structure| 42327-52-6

[ 42327-52-6 ]

7-Methoxychroman-4-one

Similarity: 0.98

Chemical Structure| 54107-66-3

[ 54107-66-3 ]

5,7-Dimethoxychroman-4-one

Similarity: 0.94

Chemical Structure| 98232-51-0

[ 98232-51-0 ]

8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one

Similarity: 0.92

Chemical Structure| 35212-22-7

[ 35212-22-7 ]

7-Isopropoxy-3-phenyl-4H-chromen-4-one

Similarity: 0.88

Chemical Structure| 41118-21-2

[ 41118-21-2 ]

Methyl 4-oxochroman-7-carboxylate

Similarity: 0.88

Related Parent Nucleus of
[ 491-37-2 ]

Other Aromatic Heterocycles

Chemical Structure| 42327-52-6

[ 42327-52-6 ]

7-Methoxychroman-4-one

Similarity: 0.98

Chemical Structure| 54107-66-3

[ 54107-66-3 ]

5,7-Dimethoxychroman-4-one

Similarity: 0.94

Chemical Structure| 98232-51-0

[ 98232-51-0 ]

8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one

Similarity: 0.92

Chemical Structure| 55745-97-6

[ 55745-97-6 ]

Chroman-6-carbaldehyde

Similarity: 0.90

Chemical Structure| 327183-32-4

[ 327183-32-4 ]

Chroman-8-carbaldehyde

Similarity: 0.88